论文部分内容阅读
A single arm, open-label, multicenter, phase Ⅱ trial of Oxaliplatin plus capecitabine (XELOX) in the
【作 者】
:
【机 构】
:
Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
【出 处】
:
第十二届国际胃癌学术会议
【发表日期】
:
2017年4期
其他文献
Thyroid transcription factor-1(NKX2.1/TITF-1)is a member of the thyroid tissue-specific transcription factor family that has been proven to be closely associated with many human diseases.
Evaluation of HER2 expression after chemotherapy with Trastuzumab in patients with Conversion Surger
NT5E variant identified by whole-exome sequencing promotes gastric cancer peritoneal metastasis by i
Effect of Enhanced Recovery After Surgery (ERAS) on Laparoscopy-assisted Distal Subtotal Gastrectomy